Skip to main content
. 2016 Dec 28;8(36):1610–1616. doi: 10.4254/wjh.v8.i36.1610

Table 1.

Comparison of the characteristics of the controls and study patients with biopsy proven

Biopsy-proven ALD Biopsy-proven NAFLD Clinically diagnosed NAFLD Controls P value
(n = 14) (n = 9) (n = 16) (n = 10) Biopsy-proven ALD vs NAFLD
Age (yr) 53 (45-60) 54 (49-66) 49 (43-54) 51 (39-60) NS
Gender (male:female) 11:3 6:3 16:0 10:0 NS
AST (U/L) 74 (41-105) 45 (38-95) 32 (24-42) 19 (15-21) NS
ALT (U/L) 19 (13-22) 35 (27-67) 48 (35-74.5) 18 (14-20) 0.0166
Albumin (g/dL) 4.1 (3.2-4.4) 4.6 (4.1-4.7) 4.4 (4.3-4.6) 4.6 (4.3-4.8) NS
Total bilirubin (mg/dL) 1 (0.6-3.1) 0.7 (0.6-0.8) 0.8 (0.6-0.9) 0.9 (0.6-1.2) NS
Triglyceride (mg/dL) 186 (99-284) 184 (101-298) 187 (102-212) 130 (111-139) NS
HDL-cholesterol (mg/dL) 40 (30-56) 43 (29-52) 42 (39-54) 50 (42-56) NS
LDL -cholesterol (mg/dL) 75 (43-105) 116 (97-153) 122 (98-157) 113 (101-136) 0.0181
GGT (U/L) 368 (296-421) 94 (62-170) 74 (57-112) 24 (19-42) 0.0018
b/t-GGT ratio 0.1 (0.07-0.13) 0.16 (0.13-0.26) 0.18 (0.14-0.24) 0.12 (0.08-0.15) NS
m/t-GGT ratio 0.04 (0.02-0.05) 0.04 (0.02-0.05) 0.04 (0.03-0.05) 0.02 (0.02-0.03) NS
s/t-GGT ratio 0.78 (0.65-0.80) 0.55 (0.49-0.64) 0.54 (0.49-0.60) 0.4 (0.31-0.44) 0.0158
f/t-GGT ratio 0.12 (0.08-0.15) 0.18 (0.15-0.26) 0.23 (0.15-0.29) 0.45 (0.37-0.63) 0.0055
b/s-GGT ratio 0.14 (0.09-0.20) 0.33 (0.21-0.53) 0.35 (0.24-0.51) 0.29 (0.19-0.52) 0.0456
s/f-GGT ratio 6.68 (3.67-10.58) 3.1 (2.18-4.32) 2.09 (1.69-3.98) 0.96 (0.48-1.11) 0.0086

Data are presented as median (25th-75th percentile). Statistical analysis: Wilcoxon-Mann-Whitney U test. AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; GGT: Gamma-glutamyltransferase; ALD: Alcoholic liver disease; NAFLD: Non-alcoholic fatty liver disease; NS: Not significant; HDL: High density lipoprotein; LDL: Low density lipoprotein; b-GGT: Big-GGT; m-GGT: Medium-GGT; s-GGT: Small-GGT; f-GGT: Free-GGT.